Dott. Maccauro Marco
Medico
Specialty / Department
- Endocrinologia
- Medicina Nucleare
Direttore della struttutra complessa di Medicina Nucleare
Nuclear Medicine
AIRC IG 2018 (ID 21939): Personalized Therapy of Metastatic Thyroid Cancer — Biological Characterization and Optimization With ¹²⁴I PET Dosimetry: A Two-Center, Single-Arm, Phase II Prospective Study
Phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breastand colorectal cancers
Last update: 20/01/2026